REE Automotive Signs Strategic MOU with Cascadia Motion
REE Automotive (REE) announced a strategic non-binding Memorandum of Understanding with Cascadia Motion (BWA). The MOU outlines cooperation across manufacturing, commercialization, and sale of a next-generation electric drive unit based on REEcorner technology for global OEM electrification programs. The new EDU product will be jointly developed by Cascadia Motion and REE. As part of an expected phased commercial plan, including a royalty-bearing agreement, REE would grant Cascadia Motion an exclusive, time-limited option to distribute a uniquely packaged EDU that integrates Cascadia Motion's iM-125 drive unit with REEcorner technology. Together, the companies aim to offer a compact, cross-platform EDU that is designed to help OEMs accelerate EV development. The new EDU combined with REE's vehicle control units is intended to support higher levels of functional safety, including ASIL-D, and to improve efficiency and time to market through secure, stable over-the-air updates. REE also plans to provide Cascadia Motion with access to its existing EDU assembly line, tooling, inventories, and supplier network to support manufacturing of the combined EDU Units, subject to negotiation of final terms and conditions.
Trade with 70% Backtested Accuracy
Analyst Views on BWA
About BWA
About the author
Supreme Court Delays Ruling on Trump's Tariffs, $150B Refunds at Stake
- Tariff Case Pending: The U.S. Supreme Court did not issue a ruling on Trump's global tariffs, with traders pricing in a 75% chance of a favorable outcome for Trump, leaving $150 billion in refunds at stake, which could significantly impact major companies' financials.
- Escalating Legal Challenges: Major firms, including Costco and Alcoa, have filed lawsuits against the tariffs seeking refunds and injunctions against future tariffs, reflecting corporate dissatisfaction and concerns over financial implications.
- Market Reaction Expectations: Crypto traders argue that striking down Trump's tariffs would provide multiple catalysts for Bitcoin and other risk assets, as market clarity improves and corporate cost pressures ease, potentially enhancing earnings outlooks.
- Power Test: This case represents a significant test of presidential powers and will impact the global economy, with any rollback of tariffs likely to be slow and complex rather than an immediate removal of all trade barriers.
Analysts Downgrade Ventyx Biosciences Target Price to $14
- Rating Downgrade: Canaccord Genuity analyst Edward Nash downgraded Ventyx Biosciences Inc (NASDAQ:VTYX) from Buy to Hold and lowered the price target from $16 to $14, reflecting a cautious outlook on the company's future growth potential.
- Market Reaction: Ventyx Biosciences shares closed at $13.73 on Wednesday, below the new target price, indicating investor concerns about the company's prospects, which may affect short-term capital inflows.
- Industry Impact: This rating change could prompt follow-up actions from other analysts, further influencing Ventyx's market performance, especially amid increasing competition in the biotech sector.
- Investor Confidence: The downgrade may undermine investor confidence in Ventyx, particularly as the company seeks to attract more investment to support its R&D and market expansion efforts.
